The Claim
Dendritic cells within tumors upregulate the creatine transporter (Slc6a8) in response to activation signals, enabling them to import creatine to support their energy demands and inflammatory function.
What the research says
Not yet evaluated
We are still looking at what the research says.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In tumors, dendritic cells increase production of a protein called Slc6a8 to take up creatine, which provides energy for their inflammatory activity.
See the scientific wording
Dendritic cells within tumors upregulate the creatine transporter (Slc6a8) in response to activation signals, enabling them to import creatine to support their energy demands and inflammatory function.
When dendritic cells in a tumor are activated, they make more of a protein that pulls creatine inside. Inside the cell, creatine helps store and quickly release energy to keep ATP levels high. This steady energy supply keeps key signaling pathways running, which turns on genes that make the dendritic cells more active and better at stimulating killer T cells to attack the tumor.
What the research says
1 studyStudy: Creatine uptake promotes dendritic cell activation and enhances antitumor immunity
The study shows increased Slc6a8 expression in tumor-infiltrating dendritic cells and in LPS-stimulated dendritic cells, establishing that activation triggers upregulation of the creatine transporter as a metabolic adaptation.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.